schliessen

Filtern

 

Bibliotheken

Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation

Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of solid-organ transplantation (SOT) and bone marrow transplantation, and are associated with high mortality. PTLDs represent a heterogeneous group of lymphoproliferative diseases, which show a spectrum... Full description

Journal Title: International Journal of Hematology 2013, Vol.97(1), pp.117-124
Main Author: Chen, Ding-Bao
Other Authors: Song, Qiu-Jing , Chen, Yun-Xin , Chen, Yu-Hong , Shen, Dan-Hua
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: ISSN: 0925-5710 ; E-ISSN: 1865-3774 ; DOI: 10.1007/s12185-012-1244-1
Link: http://dx.doi.org/10.1007/s12185-012-1244-1
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: springer_jour10.1007/s12185-012-1244-1
title: Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
format: Article
creator:
  • Chen, Ding-Bao
  • Song, Qiu-Jing
  • Chen, Yun-Xin
  • Chen, Yu-Hong
  • Shen, Dan-Hua
subjects:
  • Hematopoietic stem cell transplantation
  • Post-transplant lymphoproliferative disorders
  • Diffuse large B cell lymphoma
  • Leukemia
  • Epstein–Barr virus
ispartof: International Journal of Hematology, 2013, Vol.97(1), pp.117-124
description: Post-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of solid-organ transplantation (SOT) and bone marrow transplantation, and are associated with high mortality. PTLDs represent a heterogeneous group of lymphoproliferative diseases, which show a spectrum of clinical, morphologic, and molecular genetic features ranging from reactive polyclonal lesions to frank lymphomas. We describe clinicopathologic features of 17 cases of PTLD after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which were analyzed by in situ hybridization for EBV and a panel of antibodies directed against numerous antigens, including CD20, PAX5, CD3, bcl-6, CD10, MUM-1/IRF4, CD138, Kappa, Lambda, CD30, CD15, and Ki67. The cases included 13 males and 4 females with a median age of 31 years (range 9–49 years) and the PTLDs developed 1.5–19 months post-transplant (mean 4.7 months). The histological types indicated five cases of early lesions, two of plasmacytic hyperplasia and three of infectious mononucleosis-like PTLD. Eight cases were polymorphic PTLD, and four were monomorphic PTLD, including three of diffuse large B cell lymphoma, and one of plasmablastic lymphoma. Foci and sheets of necrosis were observed in five cases. The infected ratio of EBV was 88.2 %. Some cases were treated by reduction of immunosuppression, antiviral therapy, donor lymphocyte infusion, or anti-CD20 monoclonal rituximab. Eight cases died. The first half year after allo-HSCT is very important for the development of PTLD. The diagnosis of PTLD relies on morphology and immunohistochemistry, and EBV plays an important role in the pathogenesis of PTLD. The prognosis of PTLD is poor, and, notably, PTLD after allo-HSCT exhibits some features different from those of PTLD after SOT.
language: eng
source:
identifier: ISSN: 0925-5710 ; E-ISSN: 1865-3774 ; DOI: 10.1007/s12185-012-1244-1
fulltext: fulltext
issn:
  • 1865-3774
  • 18653774
  • 0925-5710
  • 09255710
url: Link


@attributes
ID1524254628
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid10.1007/s12185-012-1244-1
sourceidspringer_jour
recordidTN_springer_jour10.1007/s12185-012-1244-1
sourcesystemPC
pqid1273781734
galeid321485048
display
typearticle
titleClinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
creatorChen, Ding-Bao ; Song, Qiu-Jing ; Chen, Yun-Xin ; Chen, Yu-Hong ; Shen, Dan-Hua
ispartofInternational Journal of Hematology, 2013, Vol.97(1), pp.117-124
identifier
subjectHematopoietic stem cell transplantation ; Post-transplant lymphoproliferative disorders ; Diffuse large B cell lymphoma ; Leukemia ; Epstein–Barr virus
descriptionPost-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of solid-organ transplantation (SOT) and bone marrow transplantation, and are associated with high mortality. PTLDs represent a heterogeneous group of lymphoproliferative diseases, which show a spectrum of clinical, morphologic, and molecular genetic features ranging from reactive polyclonal lesions to frank lymphomas. We describe clinicopathologic features of 17 cases of PTLD after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which were analyzed by in situ hybridization for EBV and a panel of antibodies directed against numerous antigens, including CD20, PAX5, CD3, bcl-6, CD10, MUM-1/IRF4, CD138, Kappa, Lambda, CD30, CD15, and Ki67. The cases included 13 males and 4 females with a median age of 31 years (range 9–49 years) and the PTLDs developed 1.5–19 months post-transplant (mean 4.7 months). The histological types indicated five cases of early lesions, two of plasmacytic hyperplasia and three of infectious mononucleosis-like PTLD. Eight cases were polymorphic PTLD, and four were monomorphic PTLD, including three of diffuse large B cell lymphoma, and one of plasmablastic lymphoma. Foci and sheets of necrosis were observed in five cases. The infected ratio of EBV was 88.2 %. Some cases were treated by reduction of immunosuppression, antiviral therapy, donor lymphocyte infusion, or anti-CD20 monoclonal rituximab. Eight cases died. The first half year after allo-HSCT is very important for the development of PTLD. The diagnosis of PTLD relies on morphology and immunohistochemistry, and EBV plays an important role in the pathogenesis of PTLD. The prognosis of PTLD is poor, and, notably, PTLD after allo-HSCT exhibits some features different from those of PTLD after SOT.
languageeng
source
version7
lds50peer_reviewed
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
backlink$$Uhttp://dx.doi.org/10.1007/s12185-012-1244-1$$EView_full_text_in_Springer_(Subscribers_only)
search
creatorcontrib
0Chen, Ding-Bao
1Song, Qiu-Jing
2Chen, Yun-Xin
3Chen, Yu-Hong
4Shen, Dan-Hua
titleClinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
descriptionPost-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of solid-organ transplantation (SOT) and bone marrow transplantation, and are associated with high mortality. PTLDs represent a heterogeneous group of lymphoproliferative diseases, which show a spectrum of clinical, morphologic, and molecular genetic features ranging from reactive polyclonal lesions to frank lymphomas. We describe clinicopathologic features of 17 cases of PTLD after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which were analyzed by in situ hybridization for EBV and a panel of antibodies directed against numerous antigens, including CD20, PAX5, CD3, bcl-6, CD10, MUM-1/IRF4, CD138, Kappa, Lambda, CD30, CD15, and Ki67. The cases included 13 males and 4 females with a median age of 31 years (range 9–49 years) and the PTLDs developed 1.5–19 months post-transplant (mean 4.7 months). The histological types indicated five cases of early lesions, two of plasmacytic hyperplasia and three of infectious mononucleosis-like PTLD. Eight cases were polymorphic PTLD, and four were monomorphic PTLD, including three of diffuse large B cell lymphoma, and one of plasmablastic lymphoma. Foci and sheets of necrosis were observed in five cases. The infected ratio of EBV was 88.2 %. Some cases were treated by reduction of immunosuppression, antiviral therapy, donor lymphocyte infusion, or anti-CD20 monoclonal rituximab. Eight cases died. The first half year after allo-HSCT is very important for the development of PTLD. The diagnosis of PTLD relies on morphology and immunohistochemistry, and EBV plays an important role in the pathogenesis of PTLD. The prognosis of PTLD is poor, and, notably, PTLD after allo-HSCT exhibits some features different from those of PTLD after SOT.
subject
0Hematopoietic stem cell transplantation
1Post-transplant lymphoproliferative disorders
2Diffuse large B cell lymphoma
3Leukemia
4Epstein–Barr virus
general
010.1007/s12185-012-1244-1
1English
2Springer Science & Business Media B.V.
3SpringerLink
sourceidspringer_jour
recordidspringer_jour10.1007/s12185-012-1244-1
issn
01865-3774
118653774
20925-5710
309255710
rsrctypearticle
creationdate2013
addtitle
0International Journal of Hematology
1Int J Hematol
searchscopespringer_journals_complete
scopespringer_journals_complete
lsr30VSR-Enriched:[galeid, pqid, pages]
sort
titleClinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
authorChen, Ding-Bao ; Song, Qiu-Jing ; Chen, Yun-Xin ; Chen, Yu-Hong ; Shen, Dan-Hua
creationdate20130100
facets
frbrgroupid8473986346373764909
frbrtype5
languageeng
creationdate2013
topic
0Hematopoietic Stem Cell Transplantation
1Post-Transplant Lymphoproliferative Disorders
2Diffuse Large B Cell Lymphoma
3Leukemia
4Epstein–Barr Virus
collectionSpringerLink
prefilterarticles
rsrctypearticles
creatorcontrib
0Chen, Ding-Bao
1Song, Qiu-Jing
2Chen, Yun-Xin
3Chen, Yu-Hong
4Shen, Dan-Hua
jtitleInternational Journal Of Hematology
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulast
0Chen
1Song
2Shen
aufirst
0Ding-Bao
1Qiu-Jing
2Yun-Xin
3Yu-Hong
4Dan-Hua
au
0Chen, Ding-Bao
1Song, Qiu-Jing
2Chen, Yun-Xin
3Chen, Yu-Hong
4Shen, Dan-Hua
atitleClinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation
jtitleInternational Journal of Hematology
stitleInt J Hematol
risdate201301
volume97
issue1
spage117
epage124
issn0925-5710
eissn1865-3774
genrearticle
ristypeJOUR
abstractPost-transplant lymphoproliferative disorders (PTLDs) are serious, life-threatening complications of solid-organ transplantation (SOT) and bone marrow transplantation, and are associated with high mortality. PTLDs represent a heterogeneous group of lymphoproliferative diseases, which show a spectrum of clinical, morphologic, and molecular genetic features ranging from reactive polyclonal lesions to frank lymphomas. We describe clinicopathologic features of 17 cases of PTLD after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which were analyzed by in situ hybridization for EBV and a panel of antibodies directed against numerous antigens, including CD20, PAX5, CD3, bcl-6, CD10, MUM-1/IRF4, CD138, Kappa, Lambda, CD30, CD15, and Ki67. The cases included 13 males and 4 females with a median age of 31 years (range 9–49 years) and the PTLDs developed 1.5–19 months post-transplant (mean 4.7 months). The histological types indicated five cases of early lesions, two of plasmacytic hyperplasia and three of infectious mononucleosis-like PTLD. Eight cases were polymorphic PTLD, and four were monomorphic PTLD, including three of diffuse large B cell lymphoma, and one of plasmablastic lymphoma. Foci and sheets of necrosis were observed in five cases. The infected ratio of EBV was 88.2 %. Some cases were treated by reduction of immunosuppression, antiviral therapy, donor lymphocyte infusion, or anti-CD20 monoclonal rituximab. Eight cases died. The first half year after allo-HSCT is very important for the development of PTLD. The diagnosis of PTLD relies on morphology and immunohistochemistry, and EBV plays an important role in the pathogenesis of PTLD. The prognosis of PTLD is poor, and, notably, PTLD after allo-HSCT exhibits some features different from those of PTLD after SOT.
copJapan
pubSpringer Japan
doi10.1007/s12185-012-1244-1
pages117-124
date2013-01